Abstract
The aim of this work was to investigate the possibility of using brain SPECT with 99mTc-HMPAO to estimate long-term prognosis of the development of neurocognitive deficits in patients after coronary artery bypass graft (CABG). The study included 22 patients with coronary artery disease who underwent a standard estimate of neurological status, 99mTc-HMPAO brain SPECT and neuropsychological testing before CABG, 14 days and 6 months after surgical intervention. The results showed that 99mTc-HMPAO is useful radiopharmaceutical for evaluation of long-term prognosis of the development of neurocognitive deficits in patients after CABG. Thus, in 96% of patients after CABG one could observe the early cognitive deficit, which persisted in 55% of cases after 6 months. At that, a correlation between the deterioration of long-term memory after 6 months and a decrease in perfusion in the temporal lobes was detected in the early postoperative period.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
